Pharmacokinetics of adamantane-derived actoprotectors: Bromitil experiments
L. M. Krasnykh · 1995 · Candidate dissertation, Kupavna, 1995
What does this source report?
The dissertation contents and reproduced conclusions identify a Bromitil pharmacokinetic section. The formulation is discussed as combined Bromantane and Bemitil.
- Population and setting
- Experimental pharmacokinetic programme; rat studies
- Evidence type
- Animal / experimental
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Transcription is not a verified original scan.
- Pharmacokinetic interaction does not demonstrate clinical synergy or combination safety.
- Exact formulation and experiment-level denominators require the original methods.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Dissertation excerpt transcription
Review depth: Contents and reproduced conclusions
Source access and review scope
Third-party transcription of original dissertation contents and conclusions checked; complete 162-page dissertation not recovered.
Recorded source-check date: 2026-10-02. This date does not imply a completed systematic review.
Source provenance: Dissertation transcription
Cite and trace this record
Original source: L. M. Krasnykh. Pharmacokinetics of adamantane-derived actoprotectors: Bromitil experiments Candidate dissertation, Kupavna, 1995 1995.
Molekul research summary: https://molekul.io/research/bromitil-krasnykh-1995. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Bromitil
Historical combined Bromantane–Bemitil tablet studied in experimental pharmacokinetics. Original formulation and human effectiveness remain unresolved.
Bromantane
An adamantane-derived small molecule, also known as Ladasten. The expanded archive connects clinical asthenia studies, operator experiments and preclinical mechanisms, with model-specific limitations and safety findings.
Bemitil
A benzimidazole-derived actoprotector, also indexed as bemethyl and Metaprot. Research spans patient asthenia, occupational settings, neuromuscular and liver studies, metabolism and preclinical safety; these are research contexts, not established uses.